Association of CASQ2 polymorphisms with sudden cardiac arrest and heart failure in patients with coronary artery disease

Heart Rhythm

Volumn 11, Issue 4, 2014, Pages 646-652

  Refaat, Marwan M ^c   Aouizerat, Bradley E ^b   Pullinger, Clive R ^b   Malloy, Mary ^b   Kane, John ^b   Tseng, Zian H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Calsequestrin 2; Congestive heart failure; Coronary artery disease; Genetics; Sudden cardiac arrest; Ventricular arrhythmias; Ventricular tachycardia

Indexed keywords

CALSEQUESTRIN; CALSEQUESTRIN 2; UNCLASSIFIED DRUG; CASQ2 PROTEIN, HUMAN; GENOMIC DNA;

ADULT; ARTICLE; CARDIAC PATIENT; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HEART EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUDDEN CARDIAC DEATH; AGED; COMPARATIVE STUDY; COMPLICATION; DEATH, SUDDEN, CARDIAC; GENETICS; HEART ARRHYTHMIA; HEART FAILURE; HYPERTENSION; STATISTICAL MODEL; AGE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; GENDER; GENETIC ANALYSIS; GENOTYPE; MOLECULAR PATHOLOGY;

AGED; ARRHYTHMIAS, CARDIAC; CALSEQUESTRIN; CORONARY DISEASE; DEATH, SUDDEN, CARDIAC; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84896953736     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.01.015     Document Type: Article

References (34)

1. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158-2163. (Pubitemid 33043293)
2. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998;98:2334-2351. (Pubitemid 28533855)
3. Tseng ZH. Genetic association studies of sudden cardiac death/arrest: the importance of context. Heart Rhythm 2009;6:1315-1317.
4. Friedlander Y, Siscovick DS, Weinmann S, et al. Family history as a risk factor for primary cardiac arrest. Circulation 1998;97:155-160. (Pubitemid 28124672)
5. Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation 1999;99:1978-1983. (Pubitemid 29183894)
6. Dekker LR, Bezzina CR, Henriques JP, et al. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation 2006;114:1140-1145. (Pubitemid 44386477)
7. Tseng ZH, Vittinghoff E, Musone SL, et al. Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm 2009;6:1745-1750.
8. Sotoodehnia N, Li G, Johnson CO, et al. Genetic variation in angiotensinconverting enzyme-related pathways associated with sudden cardiac arrest risk. Heart Rhythm 2009;6:1306-1314.
9. Sotoodehnia N, Siscovick DS, Vatta M, et al. Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation 2006;113:1842-1848. (Pubitemid 43739395)
10. Tseng ZH, Aouizerat BE, Pawlikowska L, et al. Common beta-adrenergic receptor polymorphisms are not associated with risk of sudden cardiac death in patients with coronary artery disease. Heart Rhythm 2008;5:814-821.
11. Refaat M, Frangiskakis JM, Grimley S, et al. The â2-adrenergic receptor Gln27 polymorphism is associated with increased ventricular arrhythmias in patients with severe heart failure. Heart Rhythm 2009;6(5S):S456.
12. Gavin MC, Newton-Cheh C, Gaziano JM, Cook NR, VanDenburgh M, Albert CM. A common variant in the beta-2 adrenergic receptor and risk of sudden cardiac death. Heart Rhythm 2011;8:704-710.
13. Aouizerat BE, Vittinghoff E, Musone SL, et al. GWAS for discovery and replication of genetic loci associated with sudden cardiac arrest in patients with coronary artery disease. BMC Cardiovasc Disord 2011;11-29.
14. Faggioni M, Knollmann BC. Calsequestrin 2 and arrhythmias. Am J Physiol Heart Circ Physiol 2012;302:H1250-H1260.
15. di Barletta MR, Viatchenko-Karpinski S, Nori A, et al. Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia. Circulation 2006;114:1012-1019. (Pubitemid 44358877)
16. 2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 2006;116:2510-2520.
17. Spooner PM. Sudden cardiac death: the larger problem...the larger genome. J Cardiovasc Electrophysiol 2009;20:585-596.
18. Westaway SK, Reinier K, Huertas-Vazquez A, et al. Common variants in CASQ2, GPD1L, and NOS1AP are significantly associated with risk of sudden death in patients with coronary artery disease. Circ Cardiovasc Genet 2011;4: 397-402.
19. Pullinger CR, Hennessy LK, Chatterton JE, et al. Familial ligand defective apolipoprotein B" identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest 1995;95:1225-1234.
20. Wong CH, Koo SH, She GQ, Chui P, Lee EJ. Genetic variability of RyR2 and CASQ2 genes in an Asian population. Forensic Sci Int 2009;192:53-55.
21. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248-249.
22. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-989. (Pubitemid 32289743)
23. Hoggart CJ, Parra EJ, Shriver MD, et al. Control of confounding of genetic associations in stratified populations. Am J Hum Genet 2003;72:1492-1504. (Pubitemid 36628388)
24. Halder I, Shriver M, Thomas M, Fernandez JR, Frudakis T. A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: utility and applications. Hum Mutat 2008;29: 648-658. (Pubitemid 351614589)
25. Tian C, Gregersen PK, Seldin MF. Accounting for ancestry: population substructure and genome-wide association studies. Hum Mol Genet 2008;17: R143-R150.
26. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909. (Pubitemid 44141658)
27. Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res 2004;95:754-763. (Pubitemid 39390577)
28. Sato Y, Ferguson DG, Sako H, et al. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem 1998;273:28470-28477. (Pubitemid 28496153)
29. Conde L, Vaquerizas JM, Dopazo H, et al. PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Res 2006;34:W621-W625. (Pubitemid 44529845)
30. Terentyev D, Nori A, Santoro M, et al. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exerciseinduced sudden cardiac death. Circ Res 2006;98:1151-1158. (Pubitemid 43948101)
31. Watanabe J, Shinozaki T, Shiba N, et al. Accumulation of risk markers predicts the incidence of sudden death in patients with chronic heart failure. Eur J Heart Fail 2006;8:237-242. (Pubitemid 43674489)
32. Villard E, Perret C, Gary F, et al. A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J 2011;32:1065-1076.
33. Fishman GI, Chugh SS, DiMarco JP, et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society workshop. Circulation 2010;122:2335-2348.
34. Morrison AC, Felix JF, Cupples LA, et al. Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium. Circ Cardiovasc Genet 2010;3:248-255.